Trials / Recruiting
RecruitingNCT05455593
Effectiveness of the Combination of Water Aerobics and Metacognitive Training
Efficacy of the Combination of Water Aerobics and Metacognitive Training (MCT) on Psychological and Physical Health Variables and Their Relationship With SP1 and SP4 Biomarkers in People With Psychosis
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Fundació Sant Joan de Déu · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess the efficacy of a combined intervention of water aerobics and Metacognitive Training (MCT), compared to each intervention separately, in people with psychosis. One purpose is to analyze the improvement of clinical, cognitive, metacognitive and psychosocial variables, motor coordination and physical health condition. Another purpose is to study the changes in SP1 and SP4 biomarker transcription levels as a function of the intervention received. The hypothesis is that the combined intervention will enhance the benefits of each intervention separately, specifically in symptoms, cognition, metacognition and psychosocial variables.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Water aerobics | 1-hour session of water aerobics per week, for 3 months. A specialized trainer will carry out water aerobics sessions and will focus on motor coordination, strength and cardiovascular workout. |
| BEHAVIORAL | Metacognitive Training (MCT) | 1-hour session of MCT per week, for 3 months. A trained psychologist will carry out the MCT sessions. MCT addresses the most common cognitive biases in psychosis. Each session will focus on one topic, such as attributional style, jumping to conclusions, theory of mind, emotion recognition, memory or empathy. |
| BEHAVIORAL | Combined intervention | Patients in this arm will participate in both in water aerobics and MCT sessions, once a week for each intervention. |
Timeline
- Start date
- 2021-08-02
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2022-07-13
- Last updated
- 2024-08-22
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05455593. Inclusion in this directory is not an endorsement.